[{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"61faa655297dbdce3748160dccb9248d10564d919592f72180766f582f696a69","section":"requirements","status":"needs_review","value_json":"{\"nodes\":[{\"children\":[\"r1\",\"r2\"],\"condition\":null,\"course\":null,\"evidence\":\"PHM SCI 770or PHARMACY 770 prior to Fall 2026\",\"id\":\"root\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770or PHARMACY 770 prior to Fall 2026\",\"id\":\"r1\",\"kind\":\"course\"},{\"children\":[],\"condition\":\"PHARMACY 770 prior to Fall 2026\",\"course\":null,\"evidence\":\"PHARMACY 770 prior to Fall 2026\",\"id\":\"r2\",\"kind\":\"condition\"}],\"notes\":[\"PHM SCI 770 mapped to allowed linked course PHMSCI 770.\",\"PHARMACY 770 is absent from linked_courses; kept as a condition leaf.\"],\"root\":\"root\",\"status\":\"needs_review\"}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"61faa655297dbdce3748160dccb9248d10564d919592f72180766f582f696a69","section":"search_profile","status":"valid","value_json":"{\"activity_tags\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"label\":\"writing\"}],\"assumed_background\":[],\"search_phrases\":[\"CNS drug designs actions and applications\",\"GABAergic adrenergic dopaminergic serotonergic opioid drugs\",\"psychiatric conditions treatment pharmaceuticals\",\"central nervous system signaling drugs\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":0,\"quote\":\"Identify GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drug classes and drug origins based in part on structural aspects of the molecule.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":1,\"quote\":\"Compare and contrast the actions of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid pharmaceuticals on chemical and electrical signaling within the Central Nervous System.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":3,\"quote\":\"Describe common / serious adverse effects of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid pharmaceuticals and methods for preventing or minimizing their occurrence.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Identify CNS drug classes by structure, compare their actions on signaling, and describe adverse effects and prevention methods.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"CNS Drug Designs, Actions, and Applications II examines molecular and anatomical factors influencing drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drug systems\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":2,\"quote\":\"Recognize the psychiatric conditions and target symptoms of these conditions that are commonly treated with GABAergic, adrenergic, dopaminergic, serotonergic, and opioid pharmaceuticals.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Psychiatric conditions and symptoms treated with CNS pharmaceuticals\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":5,\"quote\":\"Assess challenges to development and use of psychoactive pharmaceuticals that are either shared across major neurotransmitter systems or unique to specific classes of drugs.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Challenges in development and use of psychoactive pharmaceuticals\"}]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"61faa655297dbdce3748160dccb9248d10564d919592f72180766f582f696a69","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"61faa655297dbdce3748160dccb9248d10564d919592f72180766f582f696a69","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"d67d471a944eee351ea833c8e2b24579ba13d5d227ce971c08ae6bf219206d90\",\"course_id\":\"PHMSCI 771\",\"current_instructors\":[{\"instructor_uid\":\"instructor_4665262be09bc2f212f8530f\",\"message\":\"No course-specific reviews available\",\"name\":\"Charles Lauhon\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[]},{\"instructor_uid\":\"instructor_c542cb2db8a9ed5e1f19d360\",\"message\":\"No course-specific reviews available\",\"name\":\"Cody Wenthur\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[]}],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":true,\"profile_hash\":\"3f5110430805ccdd533c0c072df62d68a8a5f5441c4530bbdb15d419a199a09c\",\"quick_take\":[],\"student_experience\":[],\"task_hash\":\"9dea82ef7f2113a5605c1c6030c4f9b19967eb742cc93a78268fb92357d29f5c\",\"teaching_history\":[],\"term_id\":\"1274\",\"term_name\":\"2027 Sprng\",\"version\":3}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"fa883fb9497018048a05f07ddd4c84a6105cb8e5feada4c64a42b4e7aa09958d","section":"requirements","status":"invalid","value_json":null,"candidate_json":"{\"nodes\":[{\"children\":[\"n1\",\"n2\"],\"condition\":null,\"course\":null,\"evidence\":\"PHM SCI 770or PHARMACY 770 prior to Fall 2026\",\"id\":\"n0\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770\",\"id\":\"n1\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHARMACY\"],\"timing\":\"prior\"},\"evidence\":\"PHARMACY 770\",\"id\":\"n2\",\"kind\":\"course\"}],\"notes\":[\"The course PHARMACY 770 is mentioned in requirements_text but is not present in linked_courses. This reference is kept as a verbatim condition leaf. Status is needs_review due to this missing canonical reference.\"],\"root\":\"n0\",\"status\":\"needs_review\"}","error":"Course requirement is absent from the source links","model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"fa883fb9497018048a05f07ddd4c84a6105cb8e5feada4c64a42b4e7aa09958d","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences\"}],\"text\":\"Background in CNS pharmacology, chemical properties of drugs, and molecular signaling, typically from PHMSCI 770 or PHARMACY 770, and enrollment in the MS Pharmaceutical Sciences program.\"}],\"search_phrases\":[\"CNS drug design GABAergic adrenergic\",\"pharmaceutical applications molecular cellular\",\"PHMSCI 771 prerequisites\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\"}],\"text\":\"Written communication skills for integrating chemical, molecular, cellular, and systems information to explain drug discovery and applications.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"}],\"text\":\"PHMSCI 771 applies molecular and anatomical knowledge to understand medical applications of CNS drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"molecular and anatomical factors that influence the actions of central nervous system active drugs\"}],\"text\":\"Molecular and anatomical factors influencing CNS drug actions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\"}],\"text\":\"Medical applications of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drugs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds\"}],\"text\":\"Integration of chemical, molecular, cellular, and systems information in drug discovery and development\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"fa883fb9497018048a05f07ddd4c84a6105cb8e5feada4c64a42b4e7aa09958d","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"84670ad1c450d07f346a91a1f5d335bfa86a09dcb3db691e1fb0230d54fa7522","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770\",\"id\":\"n0\",\"kind\":\"course\"}],\"notes\":[\"The requirements_text mentions both PHM SCI 770 and PHARMACY 770. PHARMACY 770 is excluded because it is absent from the source links. Only PHM SCI 770 is included as it is present in linked_courses.\"],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"84670ad1c450d07f346a91a1f5d335bfa86a09dcb3db691e1fb0230d54fa7522","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences\"}],\"text\":\"Background in CNS pharmacology, chemical properties of drugs, and molecular signaling, typically from PHMSCI 770 or PHARMACY 770, and enrollment in the MS Pharmaceutical Sciences program.\"}],\"search_phrases\":[\"CNS drug design GABAergic adrenergic\",\"pharmaceutical applications molecular cellular\",\"PHMSCI 771 prerequisites\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\"}],\"text\":\"Written communication skills for integrating chemical, molecular, cellular, and systems information to explain drug discovery and applications.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"}],\"text\":\"PHMSCI 771 applies molecular and anatomical knowledge to understand medical applications of CNS drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"molecular and anatomical factors that influence the actions of central nervous system active drugs\"}],\"text\":\"Molecular and anatomical factors influencing CNS drug actions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\"}],\"text\":\"Medical applications of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drugs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds\"}],\"text\":\"Integration of chemical, molecular, cellular, and systems information in drug discovery and development\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"84670ad1c450d07f346a91a1f5d335bfa86a09dcb3db691e1fb0230d54fa7522","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-6556a505c10f448d98d02466","output_id":"0a1c6fdbb629744c0b37077797af06e397399a0d64f37dc4e25e8d8f747c9ab9","section":"requirements","status":"invalid","value_json":null,"candidate_json":"{\"nodes\":[{\"children\":[\"r1\",\"r2\"],\"condition\":null,\"course\":null,\"evidence\":\"PHM SCI 770or PHARMACY 770 prior to Fall 2026\",\"id\":\"root\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHM SCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770\",\"id\":\"r1\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":null,\"evidence\":\"PHARMACY 770\",\"id\":\"r2\",\"kind\":\"condition\"}],\"notes\":[\"PHARMACY 770 is not in linked_courses; kept as condition leaf.\"],\"root\":\"root\",\"status\":\"needs_review\"}","error":"Node r1: course {'course_number': 770, 'minimum_grade': None, 'subjects': ['PHM SCI'], 'timing': 'prior'} is absent from the source links (linked_courses). Standing, declared programs, and subject credit counts are condition nodes, not courses. Never invent course 0. For a source reference absent from linked_courses, use kind=condition, course=null, condition=<verbatim source clause>, children=[], and needs_review with an explanatory note. Allowed course references: [{'course_number': 770, 'subjects': ['PHMSCI']}].\nNode r2: condition None must be a nonempty literal source substring. Its evidence is 'PHARMACY 770'; copy the relevant source clause into condition, without adding or removing a negation or standing qualifier.","model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-6556a505c10f448d98d02466","output_id":"0a1c6fdbb629744c0b37077797af06e397399a0d64f37dc4e25e8d8f747c9ab9","section":"search_profile","status":"valid","value_json":"{\"activity_tags\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"label\":\"writing\"}],\"assumed_background\":[],\"search_phrases\":[\"CNS drug designs actions and applications\",\"GABAergic adrenergic dopaminergic serotonergic opioid drugs\",\"psychiatric conditions treatment pharmaceuticals\",\"central nervous system signaling drugs\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":0,\"quote\":\"Identify GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drug classes and drug origins based in part on structural aspects of the molecule.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":1,\"quote\":\"Compare and contrast the actions of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid pharmaceuticals on chemical and electrical signaling within the Central Nervous System.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":3,\"quote\":\"Describe common / serious adverse effects of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid pharmaceuticals and methods for preventing or minimizing their occurrence.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Identify CNS drug classes by structure, compare their actions on signaling, and describe adverse effects and prevention methods.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"CNS Drug Designs, Actions, and Applications II examines molecular and anatomical factors influencing drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drug systems\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":2,\"quote\":\"Recognize the psychiatric conditions and target symptoms of these conditions that are commonly treated with GABAergic, adrenergic, dopaminergic, serotonergic, and opioid pharmaceuticals.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Psychiatric conditions and symptoms treated with CNS pharmaceuticals\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":5,\"quote\":\"Assess challenges to development and use of psychoactive pharmaceuticals that are either shared across major neurotransmitter systems or unique to specific classes of drugs.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Challenges in development and use of psychoactive pharmaceuticals\"}]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-6556a505c10f448d98d02466","output_id":"0a1c6fdbb629744c0b37077797af06e397399a0d64f37dc4e25e8d8f747c9ab9","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-789789da373eecc1ff75f626","output_id":"f436652b64d075d489e6a7496da4168daacbc92684fa75872ed7ccb4f483063e","section":"requirements","status":"needs_review","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770\",\"id\":\"n0\",\"kind\":\"course\"}],\"notes\":[\"The requirements_text mentions both PHM SCI 770 and PHARMACY 770. PHARMACY 770 is excluded because it is absent from the source links. Only PHM SCI 770 is included as it is present in linked_courses.\"],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-789789da373eecc1ff75f626","output_id":"f436652b64d075d489e6a7496da4168daacbc92684fa75872ed7ccb4f483063e","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences\"}],\"text\":\"Background in CNS pharmacology, chemical properties of drugs, and molecular signaling, typically from PHMSCI 770 or PHARMACY 770, and enrollment in the MS Pharmaceutical Sciences program.\"}],\"search_phrases\":[\"CNS drug design GABAergic adrenergic\",\"pharmaceutical applications molecular cellular\",\"PHMSCI 771 prerequisites\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\"}],\"text\":\"Written communication skills for integrating chemical, molecular, cellular, and systems information to explain drug discovery and applications.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"}],\"text\":\"PHMSCI 771 applies molecular and anatomical knowledge to understand medical applications of CNS drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"molecular and anatomical factors that influence the actions of central nervous system active drugs\"}],\"text\":\"Molecular and anatomical factors influencing CNS drug actions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\"}],\"text\":\"Medical applications of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drugs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds\"}],\"text\":\"Integration of chemical, molecular, cellular, and systems information in drug discovery and development\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-789789da373eecc1ff75f626","output_id":"f436652b64d075d489e6a7496da4168daacbc92684fa75872ed7ccb4f483063e","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-79348710a077dbb34341f483","output_id":"af89841e6f4986f4c65f5ab9d96e5fae59de02dc6d114834ce4f16e569582cf3","section":"requirements","status":"needs_review","value_json":"{\"nodes\":[{\"children\":[\"r1\",\"r2\"],\"condition\":null,\"course\":null,\"evidence\":\"PHM SCI 770or PHARMACY 770 prior to Fall 2026\",\"id\":\"root\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770or PHARMACY 770 prior to Fall 2026\",\"id\":\"r1\",\"kind\":\"course\"},{\"children\":[],\"condition\":\"PHARMACY 770 prior to Fall 2026\",\"course\":null,\"evidence\":\"PHARMACY 770 prior to Fall 2026\",\"id\":\"r2\",\"kind\":\"condition\"}],\"notes\":[\"PHM SCI 770 mapped to allowed linked course PHMSCI 770.\",\"PHARMACY 770 is absent from linked_courses; kept as a condition leaf.\"],\"root\":\"root\",\"status\":\"needs_review\"}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-79348710a077dbb34341f483","output_id":"af89841e6f4986f4c65f5ab9d96e5fae59de02dc6d114834ce4f16e569582cf3","section":"search_profile","status":"valid","value_json":"{\"activity_tags\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"label\":\"writing\"}],\"assumed_background\":[],\"search_phrases\":[\"CNS drug designs actions and applications\",\"GABAergic adrenergic dopaminergic serotonergic opioid drugs\",\"psychiatric conditions treatment pharmaceuticals\",\"central nervous system signaling drugs\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":0,\"quote\":\"Identify GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drug classes and drug origins based in part on structural aspects of the molecule.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":1,\"quote\":\"Compare and contrast the actions of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid pharmaceuticals on chemical and electrical signaling within the Central Nervous System.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":3,\"quote\":\"Describe common / serious adverse effects of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid pharmaceuticals and methods for preventing or minimizing their occurrence.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Identify CNS drug classes by structure, compare their actions on signaling, and describe adverse effects and prevention methods.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"CNS Drug Designs, Actions, and Applications II examines molecular and anatomical factors influencing drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drug systems\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":2,\"quote\":\"Recognize the psychiatric conditions and target symptoms of these conditions that are commonly treated with GABAergic, adrenergic, dopaminergic, serotonergic, and opioid pharmaceuticals.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Psychiatric conditions and symptoms treated with CNS pharmaceuticals\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"official_learning_outcomes\",\"outcome_index\":5,\"quote\":\"Assess challenges to development and use of psychoactive pharmaceuticals that are either shared across major neurotransmitter systems or unique to specific classes of drugs.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Challenges in development and use of psychoactive pharmaceuticals\"}]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"042b3e251647d1269db4ed488c36e45cf1805bcc6026bf1d0486745658c2ed0d","record_version_id":"8b6ca095a2c7520e546d3c4d2569ed2eb665eb168cde2de639c02c31e13a4136","job_id":"enrich-79348710a077dbb34341f483","output_id":"af89841e6f4986f4c65f5ab9d96e5fae59de02dc6d114834ce4f16e569582cf3","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"68305504318c3f71a17d6f0976ad41e0302d75166d965834e3ffcd7d019e1e51","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":770,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 770\",\"id\":\"n0\",\"kind\":\"course\"}],\"notes\":[\"The requirements_text mentions both PHM SCI 770 and PHARMACY 770. PHARMACY 770 is excluded because it is absent from the source links. Only PHM SCI 770 is included as it is present in linked_courses.\"],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"68305504318c3f71a17d6f0976ad41e0302d75166d965834e3ffcd7d019e1e51","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences\"}],\"text\":\"Background in CNS pharmacology, chemical properties of drugs, and molecular signaling, typically from PHMSCI 770 or PHARMACY 770, and enrollment in the MS Pharmaceutical Sciences program.\"}],\"search_phrases\":[\"CNS drug design GABAergic adrenergic\",\"pharmaceutical applications molecular cellular\",\"PHMSCI 771 prerequisites\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Develops written communication skills regarding the integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds.\"}],\"text\":\"Written communication skills for integrating chemical, molecular, cellular, and systems information to explain drug discovery and applications.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS II\"},{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"Applies knowledge regarding the molecular and anatomical factors that influence the actions of central nervous system active drugs to understand the medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"}],\"text\":\"PHMSCI 771 applies molecular and anatomical knowledge to understand medical applications of CNS drugs acting on GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"molecular and anatomical factors that influence the actions of central nervous system active drugs\"}],\"text\":\"Molecular and anatomical factors influencing CNS drug actions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"medical applications of drugs acting on the GABAergic, adrenergic, dopaminergic, serotonergic, and opioid systems\"}],\"text\":\"Medical applications of GABAergic, adrenergic, dopaminergic, serotonergic, and opioid drugs\"},{\"evidence\":[{\"course_id\":\"PHMSCI 771\",\"field\":\"description\",\"quote\":\"integration of chemical, molecular, cellular, and systems information to explain the discovery, development, and applications of these compounds\"}],\"text\":\"Integration of chemical, molecular, cellular, and systems information in drug discovery and development\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"68305504318c3f71a17d6f0976ad41e0302d75166d965834e3ffcd7d019e1e51","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_c1d9f1641000e5cbaa1fc340","course_id":"PHMSCI 771","catalog_version_id":"d88a2350ceb0d6719e9a0a7773977a4f8a9c882c52ec95febb67c4d7a168b790","record_version_id":"c995164908e5864b6bd8664d7e7427f84a361c8fa36842d0e2d950df347ff9b7","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"68305504318c3f71a17d6f0976ad41e0302d75166d965834e3ffcd7d019e1e51","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"1989dc4ceafe82743b0f104299c3f7cb5d1d7060e8a75b7faba96dcc9ebeeef3\",\"course_id\":\"PHMSCI 771\",\"current_instructors\":[],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":false,\"profile_hash\":\"5cb4dabf887cdbcd8c00d5a1312e10828b95c63f30bc3ea76aea199565390d02\",\"quick_take\":[],\"student_experience\":[],\"task_hash\":\"74fb0997943e888960bbc9e47db8c4fd12e4292d55c20509d8d89db6a9910f68\",\"teaching_history\":[],\"term_id\":\"1272\",\"term_name\":\"2026 Fall\",\"version\":2}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false}]